1. PRPF19 promotes tongue cancer growth and chemoradiotherapy resistance
- Author
-
Yangqing Sun, Kaimei Cai, Changhao Huang, Xue Xia, Xueyan Chen, Qiongxuan Xie, Pei Liu, Y i Xu, Yihong He, Rui Wei, Zhengnan Ming, Qingqing Liu, and Junli Luo
- Subjects
Male ,0301 basic medicine ,DNA damage ,Biophysics ,Mice, SCID ,Radiation Tolerance ,Biochemistry ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Cell Movement ,Mice, Inbred NOD ,Tongue ,Cell Line, Tumor ,Radiation, Ionizing ,medicine ,Animals ,Humans ,Cell Proliferation ,Cisplatin ,Gene knockdown ,business.industry ,Nuclear Proteins ,Cancer ,Chemoradiotherapy ,General Medicine ,Middle Aged ,medicine.disease ,Xenograft Model Antitumor Assays ,Neoplasm Proteins ,Tongue Neoplasms ,Solute carrier family ,DNA Repair Enzymes ,030104 developmental biology ,medicine.anatomical_structure ,Drug Resistance, Neoplasm ,030220 oncology & carcinogenesis ,Cancer cell ,Cancer research ,Female ,RNA Splicing Factors ,business ,medicine.drug - Abstract
Pre-mRNA processing factor 19 (PRPF19) is a multifaceted protein and participates in DNA damage response and pre-mRNA processing. The role of PRPF19 in cancer is unclear. Here, we report that the expression of PRPF19 in human tongue cancer is associated with unfavorable prognosis. Overexpression of PRPF19 promotes while knockdown of PRPF19 inhibits tongue cancer cell migration, proliferation, and tumor growth. Overexpression of PRPF19 increases the resistance of tongue cancer cells to radiation and cisplatin treatment. Furthermore, PRPF19 regulates the expression of solute carrier family 40 member 1 (SLC40A1) and mono-ADP ribosylhydrolase 2 (MACROD2), knockdown of SLC40A1 or MACROD2 decreases the sensitivity of tongue cancer cells to radiation and cisplatin treatment. Thus, our results establish a key role of PRPF19 in tongue cancer growth and chemoradiotherapy resistance, targeting PRPF19 would be an effective therapeutic strategy for tongue cancer, especially for those resistant to chemoradiotherapy.
- Published
- 2021
- Full Text
- View/download PDF